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, hIAPP [2] [3] [4] [5] [6] and Aβ40/42 3, [8] [9] [10] ) both in vitro and in vivo 3, 8, 9, [11] [12] [13] [14] . In contrast, to our knowledge, silibinin has only been reported to inhibit hIAPP self-assembly 2, 7 .
'Colloidal': Congo red (CR) (4), a dye commonly used to detect the presence of amyloid fibrils, was initially reported to bind to numerous protein aggregates [15] [16] [17] , prevent aggregation in vitro 18, 19 and reduce neurotoxicity in vivo 20 21 . It has since been reported, however, to function via a colloidal mechanism 22 . This mode of inhibition is likely due to the ability of CR to self-assemble into micelle-like species, driven by stacking of its aromatic rings 23 .
'Non-specific': 1H-benzimidazole-2-sulfonic acid (1H-B-SA) (5), previously not assessed against hIAPP, was included in the analysis as it possesses a sulfonic acid moiety and is aromatic in nature. Tramiprosate (6) has been used as a negative control for hIAPP inhibition in vitro 1, 24 .
'Negatives': The non-steroidal anti-inflammatory (NSAID) compounds aspirin (7) and ibuprofen (8) , plus benzimidazole (9) and hemin (10), contain charged and/or aromatic functional groups which are prevalent in known amyloid inhibitors, but have not previously been assessed for their interaction with hIAPP. Aspirin has been reported to inhibit fibrillogenesis of Aβ40 and Aβ42 25, 26 , and ibuprofen to reduce cognitive deficits in vivo 27, 28 and also to reduce Aβ aggregation in vitro 29, 30 . Benzimidazole was used in the screen described here to determine whether the non-specific interaction observed between hIAPP and 1H-B-SA results from the presence of a negatively charged sulfonated group interacting with the positively charged hIAPP in the gas-phase. Hemin has been reported previously to inhibit fibrillogenesis of Aβ 19, 31 , however, it has not been assessed for its interactions with hIAPP or any effect on self-assembly. 
Comparisons of hIAPP monomer drift times in the absence (black) or presence (green) of excess FG. (a) Arrival time distribution (ATD) of the hIAPP 3+ monomer ions displays one distinct conformer (drift time = ~5.8 ms) and a small component of a more extended conformation (drift time = ~7.0 ms) in the absence and presence of FG; (b) Arrival time distribution (ATD) of the hIAPP 2+ monomer ions displays two distinct conformers in the absence of FG (drift times = ~7.1 and ~9.6 ms). In the presence of FG, the hIAPP 2+ monomer displays three distinct conformers (drift times = ~5.3, ~6.3 and ~9.6 ms); (c) ESI-IMS-MS Driftscope plots of monomeric conformers observed for hIAPP alone; and (d) when FG is present at a 10-fold molar excess over hIAPP. Monomer peaks are enclosed by white boxes. Circles represent number of FG molecules bound to each species.

ion ESI mass spectra showing (a) FG; (b) EGCG; and (c) 1H-B-SA added at a 1:1 molar ratio to hIAPP (32 µM) in 10 mM (a. i, b. i, c. i) or 100 mM (a. ii, b. ii, c. ii) ammonium acetate buffer, pH 6.8. Ligand bound peptide peaks are highlighted in green (FG), pink (EGCG) and blue (1H-B-SA).
CID). CID MS/MS of FG-hIAPP (green), EGCG-hIAPP (pink) and 1H-Benz-hIAPP (blue) complexes (32 µM peptide, 320 µM ligand, 200 mM ammonium acetate buffer, pH 6.8). Relative intensity of the 2+ monomer ions bound to ligand is plotted versus increasing ion-accelerating voltage into the trap collision cell.
Figure S9. Positive ion ESI mass spectra and corresponding ESI-IMS-MS
